Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.34 |
| ▸ | EPAS1 | Q99814 | 3/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29004281 | 1.00 | LMNA (0.43) | LMNAHIF1AEPAS1 | |
| SCHEMBL17135371 | 1.00 | LMNA (0.43) | LMNAHIF1AEPAS1 | |
| SCHEMBL1773307 | 1.00 | LMNA (0.43) | LMNAHIF1AEPAS1 | |
| SCHEMBL3701351 | 1.00 | LMNA (0.43) | LMNAHIF1AEPAS1 | |
| SCHEMBL17135372 | 1.00 | LMNA (0.43) | LMNAHIF1AEPAS1 | |
| SCHEMBL17352702 | 1.00 | LMNA (0.43) | LMNAHIF1AEPAS1 | |
| SCHEMBL387190 | 1.00 | LMNA (0.43) | LMNAHIF1AEPAS1 | |
| SCHEMBL1245200 | 1.00 | LMNA (0.43) | LMNAHIF1AEPAS1 | |
| SCHEMBL182183 | 1.00 | LMNA (0.43) | LMNAHIF1AEPAS1 | |
| SCHEMBL387225 | 1.00 | LMNA (0.43) | LMNAHIF1AEPAS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240229089-A1 | A process for enzymatic synthesis of amides from amines and carboxylic acids or esters | XP CHEMISTRIES AB (SE) | 2024-07-11 | — | — | US | disclosed |
| CN-118139909-A | Beta-methyl-delta-valerolactone based polymer | 株式会社可乐丽 | 2024-06-04 | — | — | CN | disclosed |
| CN-118139926-A | Resin composition | 株式会社可乐丽 | 2024-06-04 | — | — | CN | disclosed |
| CN-117597449-A | Method for the enzymatic synthesis of amides from amines and carboxylic acids or esterases | XP化学有限公司 | 2024-02-23 | — | — | CN | disclosed |
| EP-4308714-A1 | A PROCESS FOR ENZYMATIC SYNTHESIS OF AMIDES FROM AMINES AND CARBOXYLIC ACIDS OR ESTERS | XP Chemistries AB (SE) | 2024-01-24 | — | — | EP | disclosed |
| WO-2023225216-A1 | FLUORINATED POLYMERIZATION CATALYSTS AND METHODS OF MAKING AND USING THE SAME | UNIVERSITY OF HOUSTON SYSTEM (US) | 2023-11-23 | — | — | WO | disclosed |
| WO-2023068345-A1 | Β-METHYL-δ-VALEROLACTONE POLYMER | 株式会社クラレ | 2023-04-27 | — | — | WO | disclosed |
| WO-2023068346-A1 | Β-METHYL-δ-VALEROLACTONE POLYMER | 株式会社クラレ | 2023-04-27 | — | — | WO | disclosed |
| WO-2023068348-A1 | RESIN COMPOSITION | 株式会社クラレ | 2023-04-27 | — | — | WO | disclosed |
| CN-103725652-B | A kind of acyl-CoA synthetase and application thereof | 无锡新和源发酵技术研究院有限公司 | 2016-06-29 | — | — | CN | disclosed |
| US-20070105933-A1 | Amino alcohol compounds | SANKYO COMPANY, LIMITED (JP) | 2007-05-10 | — | — | US | disclosed |
| EP-1300405-B1 | AMINO ALCOHOL DERIVATIVES | SANKYO CO (JP) | 2007-04-18 | — | — | EP | disclosed |
| US-7199150-B2 | Amino alcohol compounds | SANKYO COMPANY, LIMITED (JP) | 2007-04-03 | — | — | US | disclosed |
| US-6964976-B2 | Amino alcohol derivatives | SANKYO COMPANY, LIMITED (JP) | 2005-11-15 | — | — | US | disclosed |
| US-20050043386-A1 | Amino alcohol derivatives or phosphonic acid derivatives and pharmaceutical compositions containing these | SANKYO COMPANY, LIMITED (JP) | 2005-02-24 | — | — | US | disclosed |
| EP-1471054-A1 | AMINO ALCOHOL DERIVATIVE OR PHOSPHONIC ACID DERIVATIVE AND MEDICINAL COMPOSITION CONTAINING THESE | Sankyo Company, Limited (JP) | 2004-10-27 | — | — | EP | disclosed |
| US-20040132784-A1 | Amino alcohol derivatives | SANKYO COMPANY, LIMITED (JP) | 2004-07-08 | — | — | US | disclosed |
| US-6723745-B2 | PREVENTION OR TREATMENT OF AUTOIMMUNE DISEASE IN WARM BLOODED ANIMAL | SANKYO COMPANY, LIMITED (JP) | 2004-04-20 | — | — | US | disclosed |
| US-20030236297-A1 | Amino alcohol derivatives | SANKYO COMPANY, LIMITED (JP) | 2003-12-25 | — | — | US | disclosed |
| EP-1300405-A1 | AMINO ALCOHOL DERIVATIVES | Sankyo Company, Limited (JP) | 2003-04-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030236297-A1 | Amino alcohol derivatives | CD4, ADH1C, ADH1A | LMNA 3703/4885HIF1A 2134/4885EPAS1 2644/4885 |
| US-20050043386-A1 | Amino alcohol derivatives or phosphonic acid derivatives and pharmaceutical compositions containing these | PHOSPHO1, CD4, FCGRT | LMNA 4143/4885HIF1A 1588/4885EPAS1 647/4885 |
| US-20040132784-A1 | Amino alcohol derivatives | CD4, ADH1C, ADH1A | LMNA 3703/4885HIF1A 2134/4885EPAS1 2644/4885 |
| US-20070105933-A1 | Amino alcohol compounds | ADH1C, C9, SSB | LMNA 1187/4885HIF1A 1275/4885EPAS1 784/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.